In another experiment about the alternative NFκB pathway, NIK SMI1 was shown to be a potent small-molecular inhibitor of NIK, which selectively repressed the non-canonical NFκB pathway and mitigated SLE in mice (116). The gene discussed is NFKB1; the disease is systemic lupus erythematosus.